Denver, Colorado – TheNewswire - December 10, 2020 – CBD Global Sciences, Inc. (CSE:CBDN), (CNSX.CBDN.CN), (“CBD Global” or the “Company”), today announced that it will be presenting at the Annual LD Micro Main Event to be held virtually from December 14-15, 2020. Brad Wyatt, CEO is scheduled to present on Tuesday, December 15th at 7:40am Pacific time.
“It is an incredible opportunity for the team at CBD Global Sciences” stated Brad Wyatt. “It is an honor to be selected to present at the LD Micro Convention and I am excited to share with the investors more about our company and growth opportunities in 2021! “
From the Founder of LD Micro "I am delighted to welcome CBD Global to our Main Event as a first-time presenter. Both of our companies believe that growth truly comes from innovation, and once this COVID thing gets controlled, I plan on visiting their farm in Colorado and seeing firsthand what makes these guys special." stated Chris Lahiji, Founder of LD Micro.
About LD Micro/SEQUIRE
LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit ldmicro.com.
The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe.
In September 2020, LD Micro. Inc. was acquired by SRAX, Inc., a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.
ABOUT CBD GLOBAL SCIENCES INC.
CBD Global Sciences, Inc., is a vertically integrated hemp-based CBD producer and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Confectionary and Hydration (flat and sparkling water). CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.
For further information, please contact, Investor Relations, (888) 401-2239, info@cbdglobalsciences.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES
Copyright (c) 2020 TheNewswire - All rights reserved.
